90 related articles for article (PubMed ID: 2130805)
21. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
23. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
24. [Changes in NK cell activity in patients with acute leukemia].
Soucek J; Sedlácková M; Lindnerová G
Cas Lek Cesk; 1990 Oct; 129(43):1345-8. PubMed ID: 2249230
[TBL] [Abstract][Full Text] [Related]
25. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
26. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis).
Maggi E; Parronchi P; Del Prete G; Ricci M; Bosi A; Moretta L; Romagnani S
J Immunol; 1986 Feb; 136(4):1516-20. PubMed ID: 3080527
[TBL] [Abstract][Full Text] [Related]
27. [Cytotoxic activity of K-lymphocytes (killer cells) in Hodgkin's disease].
Górska B; Konopka L; Seyfried H; Pawelski S
Pol Tyg Lek; 1980 Aug; 35(33):1249-51. PubMed ID: 7433209
[No Abstract] [Full Text] [Related]
28. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
[TBL] [Abstract][Full Text] [Related]
29. [Detection of natural killer cells activity in patients with laryngeal carcinoma using the 51Cr release assay].
Yang YB
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990; 25(1):42-4, 63. PubMed ID: 2363975
[TBL] [Abstract][Full Text] [Related]
30. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
31. Influence of chemotherapy on the phagocytic activity of mononuclear cells in patients with Hodgkin's disease.
Süss J; Bakács T; Molnár Z
Allerg Immunol (Leipz); 1984; 30(4):251-4. PubMed ID: 6084424
[TBL] [Abstract][Full Text] [Related]
32. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
[TBL] [Abstract][Full Text] [Related]
33. Alteration of natural killer cell subsets (two color analysis) and their activity in peripheral blood in inflammatory bowel disease.
Hirata I; Hayashi K; Asada S; Miyoshi H; Iwakoshi K; Ohshiba S
Bull Osaka Med Coll; 1990 Nov; 36(1-2):47-55. PubMed ID: 2135644
[TBL] [Abstract][Full Text] [Related]
34. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
35. The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease.
Frydecka I; Boćko D; Kosmaczewska A; Ciszak L; Morilla R
Br J Cancer; 2001 May; 84(10):1339-43. PubMed ID: 11355944
[TBL] [Abstract][Full Text] [Related]
36. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.
Tajima F; Kawatani T; Endo A; Kawasaki H
Leukemia; 1996 Mar; 10(3):478-82. PubMed ID: 8642865
[TBL] [Abstract][Full Text] [Related]
38. [Age-related characteristics of the natural cytotoxicity system in patients with multiple sclerosis and their possible relation to the pathogenesis of the disease].
Cheknev SB; Latysheva OL; Tunkel' OI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):13-6. PubMed ID: 1647612
[TBL] [Abstract][Full Text] [Related]
39. Two patterns of NK activity changes following blood donation: decrease in the beginners and restoration in regular blood bank donors.
Lasek W; Jakóbisiak M; Grochowska M; Płodziszewska M; Szczytnicki W
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):191-4. PubMed ID: 1300983
[TBL] [Abstract][Full Text] [Related]
40. [Immune profile in patients with Hodgkin's disease in long-term remission after cytostatic chemotherapy].
Nagel GA; Pietra CD; Hartmann D; Rosenthal M; Albrecht R; Obrist R; Obrecht P
Schweiz Med Wochenschr; 1979 Jan; 109(2):45-51. PubMed ID: 311514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
